Hank Mansbach is the founder of 89bio. Backed by OrbiMed Israel, OrbiMed US, Longitude Capital. Based in San Francisco, United States.
Hank Mansbach, M.D., was appointed as the chief medical officer of 89bio on January 3, 2019. He oversees the development of 89bio's pipeline, including BIO89-100, an investigational product for NASH. With over two decades of clinical, regulatory, and medical affairs experience, he has worked across all stages of product development in various disease states.
Full founder directory · Investor directory · Company funding database · Fundraising library